Navigation Links
New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir

oncomitant oral antidiabetes treatment may require adjustment. Levemir® should not be diluted or mixed with any other insulin preparations or used in insulin infusion pumps. Inadequate dosing or discontinuation of treatment may lead to hyperglycemia and, in patients with type 1 diabetes, diabetic ketoacidosis. Insulin may cause sodium retention and edema, particularly if previously poor metabolic control is improved by intensified insulin therapy. Dose and timing of administration may need to be adjusted to reduce the risk of hypoglycemia in patients being switched to Levemir from other intermediate or long-acting insulin preparations. The dose of Levemir may need to be adjusted in patients with renal or hepatic impairment.

*Whether the observed differences in weight represent true differences in the effects of Levemir® and other therapies is not known, since these trials were not blinded and the protocols (e.g., diet and exercise instructions and monitoring) were not specifically directed at exploring hypotheses related to weight effects. The clinical significance of the observed differences has not been established.

Prescribing information for Levemir® is available by contacting Novo Nordisk or visiting novonordisk-us.com.

Levemir® and FlexPen® are registered trademarks of Novo Nordisk A/S.

# # #


Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 23,600 e
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:5/26/2015)... NEW YORK , May 26, 2015  Shapiro+Raj, ... Kim Mizrahi , PhD, to Managing Director. In ... York strategy for CarbonSix, Shapiro+Raj,s pharmaceutical practice ... capability. Shapiro+Raj has been on a strong ... adding a number of new assignments from existing clients ...
(Date:5/26/2015)... 2015  Caris Life Sciences®, a leading biotechnology company ... announced the designation of Virginia Cancer Specialists ... serving thousands of cancer patients each year ... center of excellence site in the Caris Centers of ... "As the largest community-based practice in the northern ...
(Date:5/26/2015)... 26, 2015 For the Last ... of Life Throughout Europe, the Middle East ... Astellas Pharma EMEA is celebrating its 10 year ... the historic merger of Japanese pharmaceutical companies Yamanouchi and ... to turning science into value for patients through its ...
Breaking Medicine Technology:Shapiro+Raj Promotes Kim Mizrahi to Managing Director for New York 2Caris Life Sciences Designates Virginia Cancer Specialists as a Caris Center of Excellence 2Caris Life Sciences Designates Virginia Cancer Specialists as a Caris Center of Excellence 3Caris Life Sciences Designates Virginia Cancer Specialists as a Caris Center of Excellence 4Astellas Pharma EMEA Celebrates Its 10th Anniversary 2Astellas Pharma EMEA Celebrates Its 10th Anniversary 3Astellas Pharma EMEA Celebrates Its 10th Anniversary 4
... Sangart, Inc., a privately,held biopharmaceutical company focused ... today announced that it has,completed enrollment in a ... The completed study of 460 patients is ... conducted at 36 academic medical centers in the,United ...
... After completing its review of safety,and efficacy ... (DSMB) has once again recommended that the two ... FAME(TM) (Fluocinolone,Acetonide in Diabetic Macular Edema) Study can ... is studying the use of Medidur FA for,the ...
Cached Medicine Technology:Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan 2DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME 2DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME 3
(Date:5/26/2015)... 26, 2015 Scientists at the University ... to help advanced mesothelioma patients benefit from immunotherapy; surgery ... an article on the new research. Click here ... departments of thoracic surgery and pulmonology theorized that, because ... immune system attack, immunotherapy drugs might work better if ...
(Date:5/26/2015)... 2015 ProTrailer Network is a new ... Pro X . This Effect includes 30 all ... styled text. , ProTrailer Network allows users to ... can easily complement any form of media project. FCPX ... can make professional looking openers. , ProTrailer Network includes ...
(Date:5/26/2015)... MN (PRWEB) May 26, 2015 Learning ... product line, Nutrition Education Cards . These cards ... Featuring engaging photography and simple, easy-to-read text, these new ... educators . They offer practical nutrition tips and suggestions ... Current titles available are: , + MyPlate: Eat for ...
(Date:5/26/2015)... 26, 2015 DENVER (May 26, 2015) ... evolves, it is also experiencing many of the growing ... mainstream counterparts, one major issue that cannabis companies now ... tons of paper and plastic that marijuana growers, dispensaries ... see waste we see the opportunity to enhance our ...
(Date:5/26/2015)... May 26, 2015 The European imaging IT ... over 45% of healthcare providers plan to make purchases. ... industry report. Data collected from these participants show that speech ... takes a back seat. , “Many imaging IT vendors ... said peer60 CEO Jeremy Bikman. “This report details the European ...
Breaking Medicine News(10 mins):Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 2Health News:Colorado Cannabis Business Expands its Recycling Initiative, to Encourage Marijuana Retailers to Keep Their Businesses Green 3Health News:peer60 report: European Healthcare IT Imaging Purchases: 2015 2
... and other signs of memory loss sometimes appear, prompting elderly ... may be experiencing early symptoms of Alzheimer,s disease (AD), the ... older. But even when early memory problems suggest the ... patients are at high risk while others are not. The ...
... WEDNESDAY, Oct. 19 (HealthDay News) -- Women living in poor ... 2 diabetes than those who move into more advantaged areas, ... its kind, researchers provided women living in high-poverty areas with ... After 10 years of living in the new areas, those ...
... Gardner HealthDay Reporter , WEDNESDAY, Oct. 19 ... radiation after a lumpectomy have significantly fewer recurrences and, ... radiation, new research says. The study also ... breast-conserving surgery, as deaths from any cause were also ...
... spitting up, irritability, and unexplained crying in infants can ... drugs for these symptoms in an effort to treat ... an uncommon cause of these symptoms in otherwise thriving ... in The Journal of Pediatrics , Eric Hassall, ...
... 2011 A recent UT Southwestern Medical Center study found ... insufficient estrogen receptors in specific parts of the brain may ... metabolism," said Dr. Deborah Clegg, associate professor of internal medicine ... Cell Metabolism . "We hadn,t previously thought of sex ...
... is everything when treating patients with both HIV and tuberculosis. ... TB treatment, rather than two months as is the current ... clinical trial in Cambodia led by researchers at Children,s Hospital ... study,s results reported by Anne Goldfeld, MD, of the ...
Cached Medicine News:Health News:Combination of available tests helps predict Alzheimer's disease risk 2Health News:Neighborhood Can Affect Obesity, Diabetes Risk 2Health News:Neighborhood Can Affect Obesity, Diabetes Risk 3Health News:Breast Radiation After Lumpectomy Saves Lives: Study 2Health News:Are acid-suppressing drugs prescribed too often in infants? 2Health News:UT Southwestern study shows estrogen works in the brain to keep weight in check 2Health News:Early HIV treatment dramatically increases survival in patients co-infected with tuberculosis 2Health News:Early HIV treatment dramatically increases survival in patients co-infected with tuberculosis 3
Inquire...
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
Silicone Compression Mat, Bulk...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Medicine Products: